Trial
NCT03685773
The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Albert Einstein College of Medicine
Collaborators
—
Condition
Diabetes Mellitus, Type 2
Intervention
Diazoxide
Why stopped
Permanently terminated due to COVID-19 given the poor vaccine penetrance in liver transplant recipients.
This is not a suspension of IRB approval.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-05